Literature DB >> 15804962

Quantitative assessment of spasticity in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

J R Zunt1, S M Montano, J O V Alarcón, W T Longstreth, R Price, K K Holmes.   

Abstract

People with human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) develop spasticity. The authors examined 34 patients with HAM/TSP in Perú using a device that measures tone in the gastroc-soleus-Achilles tendon unit and provides a quantitative spasticity assessment (QSA). Tone in the 34 patients was more than double that of women with asymptomatic HTLV-I infection. The device may help to track progression in HTLV-I infection.

Entities:  

Mesh：

Year:  2005        PMID： 15804962     DOI： 10.1080/13550280590900571

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


  10 in total

1.  HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators.

Authors:  E L Murphy; J Fridey; J W Smith; J Engstrom; R A Sacher; K Miller; J Gibble; J Stevens; R Thomson; D Hansma; J Kaplan; R Khabbaz; G Nemo
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

2.  Spasticity: quantitative measurements as a basis for assessing effectiveness of therapeutic intervention.

Authors:  J F Lehmann; R Price; B J deLateur; S Hinderer; C Traynor
Journal:  Arch Phys Med Rehabil       Date:  1989-01       Impact factor: 3.966

3.  Tropical spastic paraparesis. A clinical study of 50 patients from Tumaco (Colombia) and review of the worldwide features of the syndrome.

Authors:  G C Román; L N Román
Journal:  J Neurol Sci       Date:  1988-10       Impact factor: 3.181

4.  Quantitative assessment of subclinical spasticity in human T-cell lymphotropic virus type I infection.

Authors:  J R Zunt; J O Alarcón; S Montano; W T Longstreth; R Price; K K Holmes
Journal:  Neurology       Date:  1999-07-22       Impact factor: 9.910

Review 5.  [The recent advances of HAM/TSP research].

Authors:  M Osame
Journal:  Rinsho Shinkeigaku       Date:  1999-12

6.  Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad.

Authors:  E M Maloney; F R Cleghorn; O S Morgan; P Rodgers-Johnson; B Cranston; N Jack; W A Blattner; C Bartholomew; A Manns
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-02-01

7.  Discrepancy, coincidence or evidence in chronic idiopathic spastic paraparesis throughout the world. A meta-analysis on 2811 patients.

Authors:  F E Leon-S; C M Costa; N Gaffga
Journal:  Arq Neuropsiquiatr       Date:  1997-09       Impact factor: 1.420

Review 8.  An HTLV-I vaccine: why, how, for whom?

Authors:  G de Thé; R Bomford
Journal:  AIDS Res Hum Retroviruses       Date:  1993-05       Impact factor: 2.205

9.  Interrater reliability of a modified Ashworth scale of muscle spasticity.

Authors:  R W Bohannon; M B Smith
Journal:  Phys Ther       Date:  1987-02

10.  Quantitative measurement of spasticity in children with cerebral palsy.

Authors:  R Price; K F Bjornson; J F Lehmann; J F McLaughlin; R M Hays
Journal:  Dev Med Child Neurol       Date:  1991-07       Impact factor: 5.449
  10 in total
  2 in total

1.  Isokinetic trunk and knee muscle strengths and gait performance in walking patients with T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP).

Authors:  Masashi Miyazaki; Harutoshi Sakakima; Tatsushi Goto; Ryoji Kiyama; Toshio Matsuzaki; Kosei Ijiri; Yoshihiro Yoshida
Journal:  J Jpn Phys Ther Assoc       Date:  2011

2.  Human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis: viral load and muscle tone are correlated.

Authors:  J R Zunt; S M Montano; I Beck; J Ov Alarcón; L M Frenkel; C T Bautista; R Price; W T Longstreth
Journal:  J Neurovirol       Date:  2006-12       Impact factor: 2.643
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.